Californian marketing company BlueLithium has launched a new
web-based solution to help pharma companies overcome the challenges
of recruiting patients for clinical trials.
Hiring and retaining the right staff the right staff
represents the biggest challenge to contract research organisations
(CROs) operating in India, says Nicholas Piramal.
Pfizer is considering offers from investors in a bid to spin off
its drug research and development laboratory in Japan and make it
an independent entity, according to media reports.
Outsourcing to Asia has become a common practice among the pharma
industry but the trend has still some way to run, according to
recently released market research.
Averion has formed a new partnership in South America's clinical
trial hotspot Brazil - as it continues to tip-toe beyond North
America and Europe into emerging markets.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community of late, involving Holmes Biopharma,
MDS Pharma, the Pharmaceutical Society of India, and Huclin
Research.
In terms of contract research organisations (CROs), bigger is
actually better, reveals a recent Lehman Brothers survey, which
offers some fresh insight into this growing industry.
Two North American contract research organisation (CROs) have this
week announced acquisitive moves into emerging clinical trials
markets, while a third firm has extended an Asian partnership, as
the emerging market migration continues.
'Legislative chaos' has been preventing Poland from reaching its
full potential in the increasingly competitive central Eastern
European (CEE) region, although progress is being made.
etrials and Clinphone, two big players in the eclinical industry
are struggling to keep their heads above water as both companies'
recent woes have impacted their bottom line.
Russian contract research organisation (CRO) Synergy Research Group
has hooked up with a US-based CRO in a bid to expand its services
to North America.
Pfizer, among others, recently offered an insight into R&D
outsourcing in Japan, where this services market is still fairly
immature, with growth potential in several key areas.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Innovaderm
Research, Target Health, Qualia Clinical Service, and Quintiles.
Parexel has posted strong financial results for the fourth quarter
of its fiscal year while it is finally starting to reap the fruits
of its labour in the medical communications business.
PharmaNet has reported second quarter results that place it back in
the red after it had only just clawed its way back into the black
in the first quarter, following a string of quarterly losses.
MDS Pharma Services has announced it is expanding its development
and regulatory services (DRS) business in Europe while its
bioanalytical operations are still struggling.
New data show Russia's clinical trials industry may have been
impacted by the recent temporary biologics ban. Meanwhile the
country is attempting to introduce tighter clinical trial
regulations.
Pharmaceutical Product Development (PPD) is planning to expand its
operations in Scotland and more than double its workforce over the
next three years.
PRA said it signed an agreement with equity firm Genstar Capital to
be bought back by the firm for around $790m (€580m) while the CRO
posted a 90 per cent tumble in profit in Q2 due to heavy
restructuring charges.
The total contract research organisation (CRO) market is expected
to reach $24bn (€18bn) by 2010 as biopharma companies' spending on
outsourcing services continues to soar, new research reveals.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Quintiles,
dgd Research, Qualia, Alltracel and Affymetrix.
Despite the hype, countries in emerging markets are still very much
trailing behind the US in the number of Food and Drug
Administration (FDA)-approved studies being conducted, particularly
the Asia-pacific, a survey by Parexel reveals.
PPD has posted positive financial results for the second quarter of
the year in net contrast to its lacklustre performance in Q1, but
cut its earning outlook for the full year.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Cogstate, AbCRO,
Criterium, Clinquest and Octagon.
Parexel talks to Outsourcing-Pharma about its clinical research
experiences in emerging hot spot Latin America, as the contract
research organisation (CRO) has a presence in every country in this
continent that conducts international...
Holmes Biopharma has announced it plans to acquire the worldwide
rights to an improved formulation of a Phase II as inflammatory
bowel disease (IBD) drug.
Quintiles is planning to spend $19m ($14m) to consolidate its US
central lab and its clinical services office in
Georgia to one location and expand capacity at the same
time.
Adaptive trials were a hot topic at this year's Drug Information
Association (DIA) Annual Meeting, held in Atlanta. The first of a
free seminar series on the subject will also be run by three
industry pioneers next week.
PharmaNet Development Group has reached a significant turning point
in its attempt to finally close the doors on a long period of
trouble with its Phase I clinical business.
One of the most significant deals to take place in the vaccine
industry in the last ten years was signed late last night between
vaccine heavyweight Novartis and biotech firm Intercell.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Encorium,
Amarex, Paragon Biomedical, Pacific Biometrics and Parexel.
India's Reliance Life Sciences (RLS) is planning an acquisition in
Europe or in the US joining the slow infiltration of Indian firms
cementing themselves in Western markets.
This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...
In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...
Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...
